Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Animal Pharm Podcast #13: Anizome sheds light on the burgeoning animal microbiome opportunity

In this latest Animal Pharm podcast, editor Joseph Harvey finds out how addressing the microbiome is changing the way the animal health industry approaches R&D. To understand the potential of microbiome products, he spoke to Oliver Hardcastle – the chief executive of new firm Anizome.

Anizome was established by academic and industry partners earlier this year. It claims to be the first company focused on a commercial therapeutic microbiome discovery platform dedicated to animal health and nutrition.

 

In the podcast above, Mr Hardcastle explains why fully understanding the animal microbiome is crucial for the veterinary medicines sector. He also tells Animal Pharm why start-ups – with a helping hand from investors – will hold the key to animal microbiome innovation.

The podcast also highlights a connection between the human microbiome sector, where a multitude of young businesses have already secured a wealth of funding, and trends that could occur in the animal microbiome space in the near future.

Anizome draws on expertise from Baylor College of Medicine, human microbiome company Diversigen and Stonehaven Incubate.

In an interview earlier this year, Mr Hardcastle told Animal Pharm: "The microbiome is a real gateway towards personalized nutrition and precision medicine for animals, while offering a very real opportunity to replace antibiotics with microbiome-based solutions, such as live biotherapeutic products."

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AP014625

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel